NUP43 - middle region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-NUP43 - middle region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityNUP43 - middle region
Clonepolyclonal
Host SpeciesRabbit
Reactive Speciescow, dog, guinea pig, horse, human, mouse, rabbit, rat
Isotypen/a
Formataffinity purified
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against NUP43. It was validated on Western Blot using a cell lysate as a positive control.Target Description: NUP43 is the component of the Nup107-160 subcomplex of the nuclear pore complex (NPC). The Nup107-160 subcomplex is required for the assembly of a functional NPC. The Nup107-160 subcomplex is also required for normal kinetochore microtubule attachment, mitotic progression and chromosome segregation.Bidirectional transport of macromolecules between the cytoplasm and nucleus occurs through nuclear pore complexes (NPCs) embedded in the nuclear envelope. NPCs are composed of subcomplexes, and NUP43 is part of one such subcomplex, Nup107-160 (Loiodice et al., 2004 [PubMed 15146057]).[supplied
ImmunogenImmunogen: The immunogen is a synthetic peptide directed towards the middle region of human NUP43
Other Names[nucleoporin Nup43; Nucleoporin Nup43; nucleoporin Nup43; nucleoporin 43; Nup107-160 subcomplex subunit Nup43; p42]
Gene, Accession #[NUP43], Gene ID: 348995, NCBI: NP_942590, UniProt: Q8NFH3
Catalog #MBS3212477
Price$335
Order / More InfoNUP43 - middle region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.